| Product Name | NebuSelect™ Recombinant Mouse Glypican 2/GPC2, His-tag |
|---|---|
| Catalog Number | NBL-242559 |
| Alias/Synonyms | Glypican 2/GPC2; Glypican-2; 2410016G05Rik; Cerebroglycan; GPC2 |
| Appearance | see COA |
| Molecule Weight | His22-Ser556 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q8BKV1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242559-100ug | 100ug | Inquire | Inquire | |
| NBL-242559-1mg | 1mg | Inquire | Inquire | |
| NBL-242559-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse Glypican 2/GPC2, His-tag
Catalog#:
NBL-242559
Description:
NebuSelect™ Recombinant Mouse Glypican 2/GPC2, His-tag(Cat#NBL-242559) is expressed in HEK293 with His tag at the C-Terminus.It contains His22-Ser556.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 59.9 kDa. Due to autocatalytic cleavage, the protein migrates to 32-35 kDa based on Bis-Tris PAGE result.
Target Name:
Glypican 2/GPC2; Glypican-2; 2410016G05Rik; Cerebroglycan; GPC2
Target Information:
Glypicans can function as coreceptors for multiple signaling molecules known for regulating cell growth, motility, and differentiation. Some members of the glypican family, including glypican 2 (GPC2) and glypican 3 (GPC3), are expressed in childhood cancers and liver cancers, respectively. Antibody-based therapies targeting glypicans are being investigated in preclinical and clinical studies, with the goal of treating solid tumors that do not respond to standard therapies.
Amino Acid Sequence:
His22-Ser556
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.